Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Mastitis is important disease that causes huge economic losses in the dairy industry. In recent years, antibiotic therapy has become the primary treatment for mastitis, however, due to drug residue in milk and food safety factors, we lack safe and effective drugs for treating mastitis. Therefore, new targets and drugs are urgently needed to control mastitis. LXRα, one of the main members of the nuclear receptor superfamily, is reported to play important roles in metabolism, infection and immunity. Activation of LXRα could inhibit LPS-induced mastitis. Furthermore, LXRα is reported to enhance milk fat production, thus, LXRα may serve as a new target for mastitis therapy and regulation of milk fat synthesis. This review summarizes the effects of LXRα in regulating milk fat synthesis and treatment of mastitis and highlights the potential agonists involved in both issues.

Outpatient post-partum antibiotic prescription: method of identification of infection control areas demanding improvements and verification of sensitivity of infection registration.

OBJECTIVES: To evaluate data on outpatient antibiotic use in women post-labour as a potential method of monitoring infections in this group of patients. METHODS: Demographic and antibiotic prescription data originated from the registries of the National Health Fund (pol. Narodowy Fundusz Zdrowia). The measure of antibiotic use in this study was the percentage of women who purchased the drugs from prescriptions and DDDs. RESULTS: Among 67917 females who gave birth in the years 2013-14, 5050 (7.4%) purchased antibiotics prescribed by the obstetrician only. The average number of antibiotics bought per person was equivalent to ∼14 DDDs; in most cases (95.7%) these were ß-lactams. Antibiotic use occurred significantly more frequently among younger patients (11.5% patients <18 years of age), those living in rural areas (8.2%) and those who underwent Caesarean section (8.1%). No significant differences were found between the reported day of labour and the post-partum use of antibiotics. CONCLUSIONS: Antibiotic prescribing data can be used to verify/complement the information originating from hospital infection registries to monitor rates of infection in obstetric patients.

Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.

The main objectives of this study were (i) to evaluate the serum pharmacokinetic behaviour and milk penetration of marbofloxacin (MFX; 5 mg/kg), after intravenous (IV) and intramuscular (IM) administration in lactating goats and simulate a multidose regimen on steady-state conditions, (ii) to determine the minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) of coagulase negative staphylococci (CNS) isolated from caprine mastitis in Córdoba, Argentina and (iii) to make a PK/PD analysis by Monte Carlo simulation from steady-state pharmacokinetic parameters of MFX by IV and IM routes to evaluate the efficacy and risk of the emergence of resistance. The study was carried out with six healthy, female, adult Anglo Nubian lactating goats. Marbofloxacin was administered at 5 mg/kg bw by IV and IM route. Serum and milk concentrations of MFX were determined with HPLC/uv. From 106 regional strains of CNS isolated from caprine mastitis in herds from Córdoba, Argentina, MICs and MPCs were determined. MIC90 and MPC90 were 0.4 and 6.4 µg/ml, respectively. MIC and MPC-based PK/PD analysis by Monte Carlo simulation indicates that IV and IM administration of MFX in lactating goats may not be adequate to recommend it as an empirical therapy against CNS, because the most exigent endpoints were not reached. Moreover, this dose regimen could increase the probability of selecting mutants and resulting in emergence of resistance. Based on the results of Monte Carlo simulation, the optimal dose of MFX to achieve an adequate antimicrobial efficacy should be 10 mg/kg, but it is important take into account that fluoroquinolones are substrates of efflux pumps, and this fact may determine that assumption of linear pharmacokinetics at high doses of MFX may be incorrect.

[Effect of herd health management on the prevalence of Postpartum Dysgalaktie Syndrome (PPDS) and the treatment incidence]. / Auswirkungen einer Bestandesbetreuung auf das Vorkommen des Postpartalen Dysgalaktie Syndroms (PPDS) und die Tierbehandlungsinzidenz.

INTRODUCTION: The Postpartum Dysgalaktie Syndrome (PPDS) also known as metritis agalactia mastitis (MMA), is considered the most common disease of the sow after farrowing. The reasons for PPDS are multifactorial and are to be found in the areas of management and hygiene, feeding, water supply and animal specific factors such as body condition and age of the sows. In this study a veterinary herd health management was carried out in 28 pig farms with PPDS, with the aim to reduce the PPDS prevalence and animal treatment incidence (TI). In 20 of 28 problem farms the PPDS-prevalence could be decreased from 37.4% (± 21.8%) to 24.5% (± 14.1%). The TI was not significantly reduced. The most effective procedures to reduce the PPDS-prevalence were the use of a prepartal transition feed, optimizing the PPDSdiagnostic and the use of nonsteroidal antiinflammatory drugs (NSAID) and oxytocin in the PPDS-treatment.

Le syndrome de dysgalactie postpartum (PPDS), aussi appelé mammite, métrite, agalactie (MMA) est considéré comme la pathologie des truies la plus fréquente en période post partum. Ses causes sont multifactorielles et doivent être recherchées aussi bien dans le domaine de la gestion, de l'hygiène, de l'alimentation et de l'abreuvement que dans des facteurs propres aux animaux, comme la condition et l'âge. Dans le cadre de cette étude, on a effectué un suivi d'exploitation dans 28 exploitations d'élevage porcin avec une problématique de PPDS, dans le but de réduire la prévalence de cette affection et l'index des traitements. La prévalence de la PPDS s'est réduite dans 20 des 28 exploitations de 37.4% (± 21.8%) à 24.5% (± 14.1%). L'index des traitements n'a pas pu être abaissé significativement. Les mesures les plus efficaces pour abaisser la prévalence de la PPDS ont été l'utilisation d'un aliment de préparation à la mise-bas, l'optimisation du diagnostic de PPDS et l'utilisation d'antiinflammatoires non-stéroïdiens (AINS) et d'ocytocine pour traiter les cas de PPDS.

Value of tests for evaluating udder health in dairy goats: somatic cell counts, California Milk Cell Test and electrical conductivity.

The value of electric conductivity (EC), California Milk Cell Test (CMCT) and somatic cell count (SCC) as diagnostic tools was investigated in dairy goats. Conductivity colour reading correlated with SCC. Milk samples with conductivity colour red had significantly higher SCC than those with conductivity colours green and orange (P < 0.001). There were moderate positive correlations between CMCT (R2 = 0.470), and conductivity score and CMCT and conductivity colour readings (R2 = 0.597). Conductivity scores were significantly (P< 0.001) higher during and after intra-mammary treatment with Cloxamast LC and conductivity colours were significantly different between treatment and control groups (P< 0.001). There was a weak positive correlation between conductivity colour and stage of lactation (R2 = 0.317) and a moderately positive correlation between conductivity score and stage of lactation (R2 = 0.523). A moderately negative correlation was shown between milk yield and conductivity score (R2 = -0.426) and between milk yield and conductivity colour (R2 = -0.433). Moderate positive correlations were present between CMCT and SCC (R2 = 0.689) and between CMCT and stage of lactation (R2 = 0.459). CMCT ratings were significantly different (P < 0.001) for the intra-mammary treatment groups. CMCT ratings for infected and non-infected udder halves (P = 0.008) were significantly different; as were those for infected and non-infected udder halves and for left and right udder halves separately (P= 0.010). CMCT ratings for milk samples with SCC above and below 750 x 10(3) cells per ml were significantly different (P < 0.001) as well as for milk from treated and control udder halves with SCC below or above 750 x 10(3) cells per ml (P < 0.001). CMCT was found to be more accurate for indicating the absence of mastitis than for diagnosing it. There were significant differences in log SCC between treatment and control groups, during and after treatment. Infected udder halves had significantly higher log SCC than non-infected udder halves before and after treatment, but not during treatment. There was a moderate positive correlation between stage of lactation and SCC (R2 = 0.438).

Incidence of mastitis in breastfeeding women during the six months after delivery: a prospective cohort study.

OBJECTIVES: To estimate the incidence of mastitis in breastfeeding women during the first six months after delivery, and to identify the healthcare services used and treatments received by women with mastitis. DESIGN: A prospective cohort study with questionnaire and telephone follow-up. SETTING: A teaching hospital and the only private hospital offering obstetrics at the time of the study in the Lower Hunter Region, New South Wales. PARTICIPANTS: 1075 women in postnatal wards following delivery of a single infant who were breastfeeding at the time of recruitment. RESULTS: 233 women returned a questionnaire indicating they believed that they had developed mastitis during follow-up. Of these, 219 had mastitis by the study criteria, giving an estimated crude incidence of 20% (95% CI, 18%-22%) in the six months after delivery. Most cases of mastitis (75%) occurred within seven weeks after delivery. Multiple episodes of mastitis were reported by 63 women: 27 reported three or more episodes during six months. 160 women (73%) reported consulting a general practitioner about their mastitis. Despite National Health and Medical Research Council guidelines that antibiotics be continued for 10 days, 148 (87%) of the 170 women who were prescribed antibiotics for the first episode of mastitis took them for less than 10 days. CONCLUSIONS: A large proportion (20%) of women who were breastfeeding developed mastitis in the six months after delivery. As general practitioners are commonly consulted about mastitis, it is important that they know how to diagnose and treat this condition.

Conservative management of infective mastitis and breast abscesses after ultrasonographic assessment.

Current practice in this unit for a suspected breast abscess is preliminary ultrasonographic scan, aspiration of any pus, antibiotic therapy and repeat aspiration in the outpatient clinic if necessary. Inflammatory masses are treated with antibiotics alone. A retrospective review of this strategy has been made. Over a 2-year interval 53 patients were admitted to hospital with a suspected breast abscess. Twenty-two abscesses were aspirated, of which 19 resolved and three required subsequent incision and drainage. Eight patients underwent primary incision and drainage, one of whom required a second drainage procedure. In five patients the abscess discharged spontaneously before intervention. The remaining 18 patients were found on ultrasonography to have inflammation without evidence of focal pus which settled with antibiotic therapy in all but two patients. One of these was found to have an inflammatory cancer and the other developed an abscess, which was drained. Aspiration combined with ultrasonographic imaging is an effective alternative to incision and drainage.

Erythromycin.

Even with the continuing emergence of new antibiotics, erythromycin continues to be used extensively in obstetrics and gynecology. It is inexpensive, with a long history of usage and proven safety. When oral erythromycin preparations are given in the correct dose and with proper timing in relation to meals, no individual preparation offers a significant therapeutic advantage. Its uses include the treatment of respiratory tract infections, chlamydial and other genital tract infections in pregnancy, puerperal mastitis, and acute conjunctivitis of the newborn.